|
ODTX Odyssey Therapeutics Inc 1882782 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-38,262,000.00 |
| Balance Sheet |
|
Current Assets
|
$185,101,000.00 |
|
Assets
|
$229,070,000.00 |
|
Current Liabilities
|
$22,211,000.00 |
|
Liabilities
|
$49,206,000.00 |
|
Equity
|
$-523,694,000.00 |
|
Shares Out
|
2481339.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-41,035,000.00 |
|
Investing Cash Flow
|
$34,802,000.00 |
| Market Analysis |
Market Cap
|
$45,706,264.38 |
|
Price
|
$18.94 |
|
PB
|
0.43 |
|
EPS
|
-6.77 |
|
FCF
|
$-41,183,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:26 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:22 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ODTX documents filed with the SEC.
ODTX Filings
Clear
